Neuroblastoma and Alzheimer's disease brain cells contain aromatase activity

Steroids

Volumn 63, Issue 5-6, 1998, Pages 263-267

  Wozniak, Andrew ^a   Hutchison, Rosemary E ^a   Morris, Christopher M ^b   Hutchison, John B ^a  

^a BABRAHAM INSTITUTE   (United Kingdom)

^b NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

5 reductase; Alzheimer's; Aromarase; Aromarase inhibitors; Brain; Neuroblastoma

Indexed keywords

AROMATASE; AROMATASE INHIBITOR; ESTROGEN; STEROID 5ALPHA REDUCTASE;

ALZHEIMER DISEASE; ANDROGEN METABOLISM; ANIMAL CELL; BRAIN CELL; CANCER CELL CULTURE; CONFERENCE PAPER; ENZYME ACTIVITY; ENZYME ASSAY; HUMAN; HUMAN CELL; MOUSE; NERVE CELL DIFFERENTIATION; NEUROBLASTOMA; NONHUMAN; STEROIDOGENESIS;

ADULT; ALZHEIMER DISEASE; ANDROGENS; ANIMALS; AROMATASE; BRAIN; CELL DIFFERENTIATION; ESTROGENS; FEMALE; HUMANS; MALE; MICE; MICE, INBRED BALB C; NEUROBLASTOMA;

ANIMALIA;

EID: 0032076991     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(98)00029-4     Document Type: Conference Paper

References (13)

1. 1. Hutchison JB (1993). Aromatase: Neuromodulator in the control of behavior. J Steroid Biochem Mol Biol 44:509-520.
2. 2. Thompson EA, Siiteri PK (1974). The involvement of human placental microsomal cytochrome P450 in aromatization. J Biol Chem 249:5373-5378.
3. 3. Hutchison JB, Wozniak A, Beyer C, Hutchison RE (1996). Regulation of sex-specific formation of oestrogen in brain development: Endogenous inhibitors of aromatase. J Steroid Biochem Mol Biol 56:201-207.
4. 4. Celotti F, Melcangi R, Martini L (1992). The 5α-reductase in the brain: Molecular aspects and relation to brain function. Frontiers Neuroendocrinol 13:163-215.
5. 5. Negri-Cesi P, Poletti A, Celotti F (1996). Metabolism of steroids in the brain: A new insight into the role of 5α-reductase and aromatase in brain differentiation and functions. J Steroid Biochem Mol Biol 58:455-466.
6. 6. Schumacher M, Hutchison RE, Hutchison JB (1991). Inhibition of hypothalamic aromatase activity by 5-beta-dihydrotestosterone. J Neuroendocrinol 3:221-226.
7. 7. Wozniak A, Hutchison JB (1993). Action of endogenous steroid inhibitors of brain aromatase relative to Fadrozole. J Steroid Biochem Mol Biol 44:641-645.
8. 8. Demers LM (1994). Effects of Fadrozole (CGS16949A) and Letrozole (CGS20267) on the inhibition of aromatase activity in breast-cancer patients. Breast Cancer Res Treat 30:95-102.
9. 9. Wozniak A, Holman SD, Hutchison JB (1992). In vitro potency and selectivity of the non-steroidal androgen aromatase inhibitor CGS-16949A compared to steroidal inhibitors in brain tissue. J Steroid Biochem Mol Biol 43:281-287.
10. 10. Browne LJ, Gude C, Rodriguez H, Steele RE, Bhatnagar A (1991). Fadrozole hydrochloride: A potent, selective, non-steroidal inhibitor of aromatase for the treatment of estrogen-dependent disease. J Med Chem 34:725-736.
11. 11. Amri H, Silberzahn P, Al-Timimi I, Gaillard JL (1993). Aromatase activity in the mare ovary during estrous cycle. Measurement of endogenous steroids and of their in vitro inhibitory effect. Acta Endocrinol 129:536-542.
12. 12. Baulieu EE, Robel P (1990). Neurosteroids: A new brain function? J Steroid Biochem Mol Biol 37:395-403.
13. 13. Steimer T, Hutchison JB (1991). Micromethods for the in vitro study of steroid metabolism in the brain using radiolabelled tracers. In: Greenstein B (ed), Neuroendocrine Research Methods. Harwood AC, Switzerland, pp. 875-918.